Browsing by Author Rosenthal, Mark

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2011Development of the bronchial epithelial reticular basement membrane: relationship to epithelial height and age.McKay, Karen; Bush, Andrew; Elliot, John; Hislop, Alison; James, Alan; Jeffery, Peter; Payne, Donald; Rosenthal, Mark; Saglani, Sejal; Tsartsali, Lemonia; Zhu, Jie; Children's Hospital Westmead: Paediatrics & Child HealthDevelopment of the bronchial epithelial reticular basement membrane: relationship to epithelial height and age., Thorax: an international journal of respiratory medicine, vol.66, 4, 2011,pp 280-285
2016The effect of pulmonary function testing on bleomycin dosing in germ cell tumoursGrimison, Peter; Roncolato, Felicia; Stockler, Martin; Chatfield, Mark; Friedlander, Michael; Gurney, Howard; Houghton, Baerin B; Rosenthal, Mark; Thomson, Damien; Toner, Guy; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreThe effect of pulmonary function testing on bleomycin dosing in germ cell tumours, Internal Medicine Journal, vol.46, 8, 2016,pp 893-898
2015First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastomaSimes, Robert John; Brahmbhatt, Himanshu; Gan, Hui K.; Lickliter, Jason D; MacDiarmid, Jennifer; Rosenthal, Mark; Scott, Andrew M.; Solomon, Benjamin; Whittle, James R; NH&MRC Clinical Trials CentreFirst in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma, Journal of Clinical Neuroscience, vol.22, 12, 2015,pp 1889-1894
2017Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastomaBarnes, Elizabeth; Espinoza, David; King, Madeleine; Sawkins, Kate; Simes, Robert John; Cher, L; Field, Kathryn; Hovey, Elizabeth; Nowak, Anna K.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma, Journal of Neuro-Oncology, vol.133, N/A, 2017,pp 623-631
2014Neuro-oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care studyChen, James; Ratcliffe, Ann; Simes, Robert John; Hovey, Elizabeth; Rosenthal, Mark; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreNeuro-oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care study, Asia-Pacific Journal of Clinical Oncology, vol.10, 2, 2014,pp 162-167
2009An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate CancerBoyer, Michael; Gurney, Howard; Davis, Ian; Kotasek, Dusan; Pezaro, Carmel; Rosenthal, Mark; Soloman, Benjamin; Toner, Guy C.; Underhill, Craig; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer, American Journal of Clinical Oncology, vol.32, 4,pp 338-341
2011Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapyBrown, Christopher; Rosenthal, Mark; Simes, Robert John; Ananda, Sumitra; Cher, Lawrence; Dowling, Anthony; Nowak, Anna K.; Medicine Faculty Office; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentrePhase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy, Journal of Clinical Neuroscience, vol.18, 11, 2011,pp 1444-1448
2011Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancerClarke, Stephen; Abraham, R.; Broad, Adam; Burns, Ivon; Diiulio, Juliana; Galettis, Peter; Links, Matthew G.; Milner, Alvin D.; Mitchell, P.; Rosenthal, Mark; Northern Clinical School: Kolling InstituteRandomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer, Asia-Pacific Journal of Clinical Oncology, vol.7, 4, 2011,pp 376-384
2017The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)Barnes, Elizabeth; Sawkins, Kate; Simes, Robert John; Cher, Lawrence; Field, Kathryn; Fitt, G; Goh, Christine; Hovey, Elizabeth; Nowak, Anna K.; Phal, Pramit M.; Rosenthal, Mark; Wheeler, Helen; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreThe role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET), Cancer, vol.123, 18, 2017,pp 3576-3582